Cordyceps sinensis: Invitro anti-fibrotic bioactivity of natural andcultured preparations

Food Hydrocolloids

Volumn 35, Issue , 2014, Pages 444-452

  Yao, Xiaolin ^a   Meran, Soma ^b   Fang, Yapeng ^a   Martin, John ^b   Midgley, Adam ^b   Pan, Ming Ming ^c   Liu, Bi Cheng ^c   Cui, Steve W ^d,e   Phillips, Glyn O ^f   Phillips, Aled O ^b  

^a HubeiUniversityofTechnology   (China)

^b CARDIFF UNIVERSITY SCHOOL OF MEDICINE   (United Kingdom)

^c SOUTHEAST UNIVERSITY   (China)

^d NANCHANG UNIVERSITY   (China)

^e GUELPH RESEARCH AND DEVELOPMENT CENTRE   (Canada)

^f GLYNDWR UNIVERSITY   (United Kingdom)

Author keywords

Cordyceps sinensis; Fibrosis; Mycelial culture; TGF

Indexed keywords

CELL CULTURE; CELLS; CHEMICAL ACTIVATION; HYALURONIC ACID; MYCELIUM;

BENEFICIAL EFFECTS; BIO ACTIVITY; CORDYCEPS SINENSIS; FIBROSE; IN-VITRO; MYCELIAL CULTURE; NATURALLY OCCURRING; RENAL DISEASE; TGF-SS; TGF-Β1;

BIOACTIVITY;

CORDYCEPS; CORDYCEPS SINENSIS; PAECILOMYCES SINENSIS;

EID: 84886308060     PISSN: 0268005X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.foodhyd.2013.06.023     Document Type: Article

References (47)

1. Aoki H., Al-Assaf S., Katayama T., Phillips G.O. Characterization and properties of Acacia senegal (L.) Willd. var. senegal with enhanced properties (Acacia (sen) SUPER GUM (TM)): part 2-mechanism of the maturation process. Food Hydrocolloids 2007, 21(3):329-337.
2. Bommaya G., Meran S., Krupa A., Phillips A.O., Steadman R. Tumour necrosis factor-stimulated gene (TSG)-6 controls epithelial-mesenchymal transition of proximal tubular epithelial cells. International Journal of Biochemistry & Cell Biology 2011, 43(12):1739-1746.
3. Chen W., Zhang W., Shen W., Wang K. Effects of the acid polysaccharide fraction isolated from a cultivated Cordyceps sinensis on macrophages invitro. Cellular Immunology 2010, 262(1):69-74.
4. Commission, C. P. (2005). Shanghai: Commercial Press.
5. Cui J.D., Zhang B.Z. Comparison of culture methods on exopolysaccharide production in the submerged culture of Cordyceps militaris and process optimization. Letters in Applied Microbiology 2011, 52(2):123-128.
6. Ding C., Tian P.X., Xue W., Ding X., Yan H., Pan X., et al. Efficacy of Cordyceps sinensis in long term treatment of renal transplant patients. Frontiers in Bioscience (Elite Edition) 2011, 3:301-307.
7. Eddy A.A. Progression in chronic kidney disease. Advances in Chronic Kidney Disease 2005, 12(4):353-365.
8. Essawy M., Soylemezoglu O., Muchaneta-Kubara E.C., Shortland J., Brown C.B., El Nahas A.M. Myofibroblasts and the progression of diabetic nephropathy. Nephrology Dialysis Transplantation 1997, 12:43-50.
9. Fan J.M., Ng Y.Y., Hill P.A., Nikolic-Paterson D.J., Mu W., Atkins R.C., et al. Transforming growth factor ß regulates tubular epithelial myofibroblast transdifferentiation invitro. Kidney International 1999, 56:1455-1467.
10. Gabbiani G. The myofibroblast in wound healing and fibrocontractive diseases. The Journal of Pathology 2003, 200(4):500-503.
11. Goumenos D.S., Brown C.B., Shortland J., El Nahas A.M. Myofibroblasts, predictors of progression of mesangial IgA nephropathy?. Nephrology Dialysis Transplantation 1994, 9:1418-1425.
12. Goumenos D., Tsomi K., Iatrou C., Oldroyd S., Sungur A., Papaioannides D., et al. Myofibroblasts and the progression of crescentic glomerulonephritis. Nephrology Dialysis Transplantation 1998, 13(7):1652-1661.
13. Jenkins R.H., Thomas G.J., Williams J.D., Steadman R. Myofibroblastic differentiation leads to hyaluronan accumulation through reduced hyaluronan turnover. The Journal of Biological Chemistry 2004, 279(40):41453-41460.
14. Jordan J.L., Hirsch G.M., Lee T.D.G. C.sinensis ablates allograft vasculopathy when used as an adjuvant therapy with cyclosporin A. Transplant Immunology 2008, 19(3-4):159-166.
15. Kuhn C., McDonald J.A. The role of the myofibroblast in idiopathic pulmonary fibrosis. The American Journal of Pathology 1991, 138(5):1257-1265.
16. Lan H.Y., Mu W., Tomita N., Huang X.R., Li J.H., Zhu H.J., et al. Inhibition of renal fibrosis by gene transfer of inducible Smad7 using ultrasound-microbubble system in rat UUO model. Journal of the American Society of Nephrology 2003, 14(6):1535-1548.
17. Li S.P., Li P., Dong T.T., Tsim K.W. Anti-oxidation activity of different types of natural Cordyceps sinensis and cultured Cordyceps mycelia. Phytomedicine 2001, 8(3):207-212.
18. Li F.H., Liu P., Xiong W.G., Xu G.F. Effects of corydyceps polysaccharide on liver fibrosis induced by DMN in rats. Zhongguo Zhong Yao Za Zhi 2006, 31(23):1968-1971.
19. Li S.P., Tsim K.W.K. The biological and pharmacological properties of Cordyceps sinensis, a traditional Chinese medicine that has broad clinical applications 2004, Marcel Dekker, New York.
20. Liu X. Cordyceps sinensis 1998, Hong Kong Medical Publisher, Hong Kong.
21. Meran S., Thomas D., Stephens P., Martin J., Bowen T., Phillips A., et al. Involvement of hyaluronan in regulation of fibroblast phenotype. Journal of Biological Chemistry 2007, 282(35):25687-25697.
22. Ng Y.Y., Huang T.P., Yang W.C., Chen Z.P., Yang A.H., Mu W., et al. Tubular epithelial myofibroblast transdifferentiation in progressive tubulointerstitial fibrosis in 5/6 nephrectomized rats. Kidney International 1998, 54:864-876.
23. Nie S.P., Cui S.W., Phillips A.O., Xie M.Y., Phillips G.O., Al-Assaf S., et al. Elucidation of the structure of a bioactive hydrophilic polysaccharide from Cordyceps sinensis by methylation analysis and NMR spectroscopy. Carbohydrate Polymers 2011, 84:894-899.
24. Piek E., Moustakas A., Kurisaki A., Heldin C.H., ten Dijke P. TGF-(beta) type I receptor/ALK-5 and Smad proteins mediate epithelial to mesenchymal transdifferentiation in NMuMG breast epithelial cells. Journal of Cell Science 1999, 112(Pt 24):4557-4568.
25. Roberts I.S., Burrows C., Shanks J.H., Venning M., McWilliam L.J. Interstitial myofibroblasts: predictors of progression in membranous nephropathy. Journal of Clinical Pathology 1997, 50(2):123-127.
26. Ryan M.J., Johnson G., Kirk J., Fuerstenberg S.M., Zager R.A., Torok-Storb B. HK-2: an immortalized proximal tubule epithelial cell line from normal adult human kidney. Kidney International 1994, 45:48-57.
27. Shahed A.R., Kim S.I., Shoskes D.A. Down-regulation of apoptotic andinflammatory genes by Cordyceps Sinensis extract in rat kidney following ischemia/reperfusion. Transplantation Proceedings 2001, 33(6):2986-2987.
28. Shi Y., Massague J. Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell 2003, 113(6):685-700.
29. Simpson R., Meran S., Thomas D., Stephens P., Bowen T., Steadman R., et al. Age related changes in peri-cellular hyaluronan organisation leads to impaired dermal fibroblast to myofibroblast differentiation. The American Journal of Pathology 2009, 175:1915-1928.
30. Simpson R.M.L., Wells A., Thomas D., Stephens P., Steadman R., A.O.P. Ageing fibroblasts resist phenotypic maturation due to impaired hyaluronan-dependent CD44/EGF receptor signalling. The American Journal of Pathology 2009, in press.
31. Stahl P.J., Felsen D. Transforming growth factor-beta, basement membrane, and epithelial- mesenchymal transdifferentiation: implications for fibrosis in kidney disease. The American Journal of Pathology 2001, 159(4):1187-1192.
32. Wang, A. (1914). (Vol. 1). Shanghai: Gong He Shu Ju (Republic Book Store).
33. Wang S.J., Bai W., Wang C.L., Dai Z. Effects of Cordyceps sinensis on bleomycin-induced pulmonary fibrosis in mice. Zhongguo Zhong Yao Za Zhi 2007, 32(24):2623-2627.
34. Wang H.P., Liu C.W., Chang H.W., Tsai J.W., Sung Y.Z., Chang L.C. Cordyceps sinensis protects against renal ischemia/reperfusion injury in rats. Molecular Biology Reports 2012.
35. Webber J., Jenkins R.H., Meran S., Phillips A., Steadman R. Modulation of TGF{beta}1-dependent myofibroblast differentiation by hyaluronan. American Journal of Pathology 2009, 175(1):148-160.
36. Webber J., Meran S., Steadman R., Phillips A.O. Hyaluronan orchestrates TGF-beta 1 dependent maintenance of myofibroblast phenotype. Journal of Biological Chemistry 2009, 284:9083-9092.
37. Yang L.-Y., Chen A., Kuo Y.-C., Lin C.-Y. Efficacy of a pure compound H1-A extracted from Cordyceps sinensis on autoimmune disease of MRL lpr/lpr mice. Journal of Laboratory and Clinical Medicine 1999, 134(5):492-500.
38. Yang L.-Y., Huang W.J., Hsieh H.-G., Lin C.-Y. H1-A extracted from Cordyceps sinensis suppresses the proliferation of human mesangial cells and promotes apoptosis, probably by inhibiting the tyrosine phosphorylation of Bcl-2 and Bcl-XL. Journal of Laboratory and Clinical Medicine 2003, 141(1):74-83.
39. Yang J., Liu Y. Dissection of key events in tubular epithelial to myofibroblast transition and its implications in renal interstitial fibrosis. The American Journal of Pathology 2001, 159(4):1465-1475.
40. Yue K., Ye M., Zhou Z., Sun W., Lin X. The genus Cordyceps: a chemical and pharmacological review. Journal of Pharmacy and Pharmacology 2013, 65(4):474-493.
41. Zhang X.L., Bi-Cheng L., Al-Assaf S., Phillips G.O., Phillips A.O. Cordyceps sinensis decreases TGF-β1 dependent epithelial to mesenchymal transdifferentiation and attenuates renal fibrosis. Food Hydrocolloids 2012, 28:200-212.
42. Zhang Z., Wang X., Zhang Y., Ye G. Effect of Cordyceps sinensis on renal function of patients with chronic allograft nephropathy. Urologia Internationalis 2011, 86(3):298-301.
43. Zhang Q.X., Wu J.Y. Cordyceps sinensis mycelium extract induces human premyelocytic leukemia cell apoptosis through mitochondrion pathway. Experimental Biology and Medicine 2007, 232(1):52-57.
44. Zhao X., Li L. Cordyceps sinensis in protection of the kidney from cyclosporine A nephrotoxicity. Zhonghua Yi Xue Za Zhi 1993, 73(7):410-412.
45. Zhou X., Gong Z., Su Y., Lin J., Tang K. Cordyceps fungi: natural products, pharmacological functions and developmental products. Journal of Pharmacy and Pharmacology 2009, 61(3):279-291.
46. Zhu J.S., Halpern G.M., Jones K. The scientific rediscovery of an ancient Chinese herbal medicine: Cordyceps sinensis: part I. Journal of Alternative and Complementary Medicine 1998, 4:289-303.
47. Zhu J.S., Halpern G.M., Jones K. The scientific rediscovery of an ancient Chinese herbal medicine: Cordyceps sinensis: part II. Journal of Alternative and Complementary Medicine 1998, 4:429-457.